A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

BACKGROUND. A prospective, multicenter, randomized, Phase III trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) with a combination of vinorelbine and doxorubicin (NA) in the treatment of patients with advanced breast carcinoma was u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Blajman, C., Balbiani, L., Block, J., Coppola, F., Chacon, R., Fein, L., Bonicatto, S., Alvarez, A., Schmilovich, A., Delgado, F.M.
Formato: JOUR
Materias:
Advanced breast carcinoma
Combination chemotherapy
Randomized controlled trials
cyclophosphamide
doxorubicin
fluorouracil
navelbine
article
breast carcinoma
cancer combination chemotherapy
cancer staging
cancer survival
clinical trial
controlled clinical trial
controlled study
drug efficacy
drug potency
female
human
major clinical study
phase 3 clinical trial
priority journal
randomized controlled trial
Adult
Aged
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Cyclophosphamide
Disease Progression
Disease-Free Survival
Doxorubicin
Female
Fluorouracil
Humans
Middle Aged
Neoplasm Recurrence, Local
Prospective Studies
Survival Analysis
Treatment Outcome
Vinblastine
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_0008543X_v85_n5_p1091_Blajman
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Ejemplares similares